secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omega Therapeutics, Inc. (—)
CIK:        0001850838
Form:       8-K
Filed at:   2024-10-04T23:59:59+00:00
Accession:  0000950170-24-112962
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Omega Therapeutics elects Robert L. Rosiello to board as Class I director
-------------------------------------------------------------------------

- Rosiello appointed effective October 2, 2024; receives standard director compensation.
- Annual retainer of $35,000 for board service under Non-Employee Director Compensation Program.
- Initial option grant of 50,000 shares at $1.09 strike, vesting monthly over 3 years.
- No arrangement or family relationship with other directors or officers; standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850838/000095017024112962/0000950170-24-112962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850838/000095017024112962/omga-20241002.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-112962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer